EDGAR Filing Documents for 0001176256-16-000420

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001176256-16-000420

Filing Date

2016-02-09

Accepted

2016-02-09 13:17:48

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FILED PURSUANT TO RULE 424(B)(5)	nymoxprosup160209.htm	424B5	263567
2		exhibit99-1x1x1.jpg	GRAPHIC	7546
3		exhibit99-1x13x1.jpg	GRAPHIC	7336
4		exhibit99-1x48x1.jpg	GRAPHIC	7373
	Complete submission text file	0001176256-16-000420.txt		295629

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-205659 | Film No.: 161398440
SIC: 2835 In Vitro & In Vivo Diagnostic Substances